Cargando…

Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories

There is limited understanding regarding kratom use among US adults. Although motivations for use are increasingly understood, typical kratom doses, threshold of (low and high) doses for perceived effectiveness, and effects produced during cessation are not well documented. We aimed to extend prior...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Kirsten E., Rogers, Jeffrey M., Dunn, Kelly E., Grundmann, Oliver, McCurdy, Christopher R., Schriefer, Destiny, Epstein, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921773/
https://www.ncbi.nlm.nih.gov/pubmed/35300296
http://dx.doi.org/10.3389/fphar.2022.765917
_version_ 1784669392513007616
author Smith, Kirsten E.
Rogers, Jeffrey M.
Dunn, Kelly E.
Grundmann, Oliver
McCurdy, Christopher R.
Schriefer, Destiny
Epstein, David H.
author_facet Smith, Kirsten E.
Rogers, Jeffrey M.
Dunn, Kelly E.
Grundmann, Oliver
McCurdy, Christopher R.
Schriefer, Destiny
Epstein, David H.
author_sort Smith, Kirsten E.
collection PubMed
description There is limited understanding regarding kratom use among US adults. Although motivations for use are increasingly understood, typical kratom doses, threshold of (low and high) doses for perceived effectiveness, and effects produced during cessation are not well documented. We aimed to extend prior survey work by recruiting adults with current and past kratom exposure. Our goal was to better understand kratom dosing, changes in routines, and perception of effects, including time to onset, duration, and variability of beneficial and adverse outcomes from use and cessation. Among respondents who reported experiencing acute kratom effects, we also sought to determine if effects were perceived as helpful or unhelpful in meeting daily obligations. Finally, we attempted to detect any signal of a relationship between the amount of kratom consumed weekly and weeks of regular use with ratings of beneficial effects from use and ratings of adverse effects from cessation. We conducted an online survey between April-May 2021 by re-recruiting participants from a separate study who reported lifetime kratom use. A total of 129 evaluable surveys were collected. Most (59.7%) had used kratom >100 times and reported currently or having previously used kratom >4 times per week (62 weeks on average). Under half (41.9%) reported that they considered themselves to be a current “regular kratom user.” A majority (79.8%) reported experiencing acute effects from their typical kratom dose and that onset of effects began in minutes but dissipated within hours. Over a quarter reported that they had increased their kratom dose since use initiation, whereas 18.6% had decreased. Greater severity of unwanted effects from ≥1 day of kratom cessation was predicted by more weeks of regular kratom use (β = 6.74, p = 0.02). Acute kratom effects were largely reported as compatible with, and sometimes helpful in, meeting daily obligations. In the absence of human laboratory studies, survey methods must be refined to more precisely assess dose-effect relationships. These can help inform the development of controlled observational and experimental studies needed to advance the public health understanding of kratom product use.
format Online
Article
Text
id pubmed-8921773
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89217732022-03-16 Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories Smith, Kirsten E. Rogers, Jeffrey M. Dunn, Kelly E. Grundmann, Oliver McCurdy, Christopher R. Schriefer, Destiny Epstein, David H. Front Pharmacol Pharmacology There is limited understanding regarding kratom use among US adults. Although motivations for use are increasingly understood, typical kratom doses, threshold of (low and high) doses for perceived effectiveness, and effects produced during cessation are not well documented. We aimed to extend prior survey work by recruiting adults with current and past kratom exposure. Our goal was to better understand kratom dosing, changes in routines, and perception of effects, including time to onset, duration, and variability of beneficial and adverse outcomes from use and cessation. Among respondents who reported experiencing acute kratom effects, we also sought to determine if effects were perceived as helpful or unhelpful in meeting daily obligations. Finally, we attempted to detect any signal of a relationship between the amount of kratom consumed weekly and weeks of regular use with ratings of beneficial effects from use and ratings of adverse effects from cessation. We conducted an online survey between April-May 2021 by re-recruiting participants from a separate study who reported lifetime kratom use. A total of 129 evaluable surveys were collected. Most (59.7%) had used kratom >100 times and reported currently or having previously used kratom >4 times per week (62 weeks on average). Under half (41.9%) reported that they considered themselves to be a current “regular kratom user.” A majority (79.8%) reported experiencing acute effects from their typical kratom dose and that onset of effects began in minutes but dissipated within hours. Over a quarter reported that they had increased their kratom dose since use initiation, whereas 18.6% had decreased. Greater severity of unwanted effects from ≥1 day of kratom cessation was predicted by more weeks of regular kratom use (β = 6.74, p = 0.02). Acute kratom effects were largely reported as compatible with, and sometimes helpful in, meeting daily obligations. In the absence of human laboratory studies, survey methods must be refined to more precisely assess dose-effect relationships. These can help inform the development of controlled observational and experimental studies needed to advance the public health understanding of kratom product use. Frontiers Media S.A. 2022-03-01 /pmc/articles/PMC8921773/ /pubmed/35300296 http://dx.doi.org/10.3389/fphar.2022.765917 Text en Copyright © 2022 Smith, Rogers, Dunn, Grundmann, McCurdy, Schriefer and Epstein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Smith, Kirsten E.
Rogers, Jeffrey M.
Dunn, Kelly E.
Grundmann, Oliver
McCurdy, Christopher R.
Schriefer, Destiny
Epstein, David H.
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
title Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
title_full Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
title_fullStr Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
title_full_unstemmed Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
title_short Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
title_sort searching for a signal: self-reported kratom dose-effect relationships among a sample of us adults with regular kratom use histories
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921773/
https://www.ncbi.nlm.nih.gov/pubmed/35300296
http://dx.doi.org/10.3389/fphar.2022.765917
work_keys_str_mv AT smithkirstene searchingforasignalselfreportedkratomdoseeffectrelationshipsamongasampleofusadultswithregularkratomusehistories
AT rogersjeffreym searchingforasignalselfreportedkratomdoseeffectrelationshipsamongasampleofusadultswithregularkratomusehistories
AT dunnkellye searchingforasignalselfreportedkratomdoseeffectrelationshipsamongasampleofusadultswithregularkratomusehistories
AT grundmannoliver searchingforasignalselfreportedkratomdoseeffectrelationshipsamongasampleofusadultswithregularkratomusehistories
AT mccurdychristopherr searchingforasignalselfreportedkratomdoseeffectrelationshipsamongasampleofusadultswithregularkratomusehistories
AT schrieferdestiny searchingforasignalselfreportedkratomdoseeffectrelationshipsamongasampleofusadultswithregularkratomusehistories
AT epsteindavidh searchingforasignalselfreportedkratomdoseeffectrelationshipsamongasampleofusadultswithregularkratomusehistories